Grundy J E, McKeating J A, Sanderson A R, Griffiths P D
Department of Virology and Immunology, Royal Free Hospital School of Medicine, London, England.
Transplantation. 1988 Jun;45(6):1075-9.
We have previously shown that the binding of host beta 2 microglobulin (beta 2 m) by cytomegalovirus (CMV) in body fluids masks the viral antigenic determinants preventing its detection by CMV-specific monoclonal antibodies. We now report that the recognition of CMV-bound beta 2m by anti-beta 2m-specific antibodies in assays for beta 2m, results in erroneously high readings for beta 2m levels in urine specimens containing CMV. Urinary beta 2m levels have previously been reported to be elevated in patients with CMV infection--however, when virion bound beta 2m was removed by ultracentrifugation of urine specimens, the levels of free beta 2m were not found to be elevated in these patients. Since CMV is frequently excreted by transplant recipients and acquired immunodeficiency syndrome patients, our data suggest that measurements of urinary beta 2m levels in such patients are unreliable unless the urine specimens are confirmed to be free of CMV before analysis.
我们之前已经表明,体液中巨细胞病毒(CMV)与宿主β2微球蛋白(β2m)的结合会掩盖病毒抗原决定簇,从而阻止其被CMV特异性单克隆抗体检测到。我们现在报告,在检测β2m的试验中,抗β2m特异性抗体对CMV结合的β2m的识别,导致含有CMV的尿液标本中β2m水平的读数错误地偏高。此前有报道称,CMV感染患者的尿β2m水平会升高——然而,当通过尿液标本超速离心去除病毒体结合的β2m后,这些患者的游离β2m水平并未升高。由于CMV经常由移植受者和获得性免疫缺陷综合征患者排出,我们的数据表明,除非在分析前确认尿液标本不含CMV,否则对此类患者尿β2m水平的测量是不可靠的。